Ichthyosis Linearis Circumflexa

Watchlist

(log in to enable)

Retrieved

2021-01-18

Source

Wikipedia

Trials

—

Genes

SPINK5, ST14, KLK5, KLK7, FLG, NPHS1, DSG1, ELANE, VEGFA, NPHS2, POU5F1P3, SOCS5, PTGS2, PTPN11, SPINK1, DEFB4B, STAT3, TGM1, TNF, SOCS3, IVNS1ABP, MERTK, IL17F, SUB1, PTH, POU5F1P4, IL36B, IGHV1-12, ICOS, KLK14, IL22, NLRX1, IL33, APP, POU5F1, KLK6, GH1, BTD, CDSN, CCR5, CTRL, ACE, DEFB4A, DRD4, EPO, ERBB2, FLNA, GBA, GBAP1, GPT, AVP, GYPA, GYPB, GYPE, HRAS, ICAM1, IFNG, IL17A, IVL, KRAS, MIF, COX2, PI3, MTCO2P12

Drugs

6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,1-benzoxazin-4-one, Kallikrein 7 and elastase 2 inhibitor, Recombinant kallikrein inhibitor

6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,1-benzoxazin-4-one, Kallikrein 7 and elastase 2 inhibitor, Recombinant kallikrein inhibitor, Tazarotene

Interested in hearing about new therapies?

Ichthyosis linearis circumflexa is a distinctive skin condition of generalized hyperkeratosis and polycyclic and serpiginous erythematous plaques with a characteristic, migratory, double-edged scale at the margins, and is the typical cutaneous manifestation of Netherton's syndrome.^:496^:563

Ichthyosis Linearis Circumflexa

See also